Patent US2999764A successfully refreshed from Google Patents.
Patent US4405597A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4405597A Expired / Lapsed US ⏱️ 0.0 years remaining

Medicament capsules for rectal application

Assignee: Shin-Etsu Chemical Co Ltd
•
Filing: 1981-08-11
•
Granted: 1983-09-20
•
Expires: 2001-08-11
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention provides a novel means for the administration of a therapeutically effective ingredient in the form of a rectally applicable medicament capsule, in which the otherwise unavoidable extreme variation in the absorbability of the effective ingredient among the individuals rectally treated with the capsules is minimized. It has been unexpectedly found that, when the effective ingredient is contained in the capsule in the form of a liquid medicine, the osmotic pressure of the liquid content plays a very essential role in the absorption of the effective ingredient through the rectum and the variation in the absorbability of the effective ingredient among the individuals can be minimized when the osmotic pressure of the liquid content is substantially higher than the osmotic pressure of the rectal fluid with which the capsules are contacted.

Inventors

  • 👤 Yasushi Takagishi
  • 👤 Yoshio Doi
  • 👤 Kiichiro Ohsuga
  • 👤 Noboru Hoshi
  • 👤 Ltd. Shionogi & Co.

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 14:51
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/48; A61K9/4816; A61K9/02; A61K9/025

Claims Analysis

Total Claims: 3
Claim 1
Independent Claim 91 words
A method for the administration of a rectally absorbable, therapeutically effective ingredient which comprises inserting into the rectum through the anus a medicament capsule formed of a hard capsule shell made of an enterosoluble material selected from the group consisting of mixed esters of an alkylcellulose, a hydroxyalkylcellulose or a hydroxyalkyl alkylcellulose esterified with acidic succinyl groups and aliphatic monoacyl groups, and encapsulating a liquid content containing the rectally absorbable, therapeutically effective ingredient, the osmotic pressure of the liquid content being substantially higher than the osmotic pressure of the rectal fluid.
Claim 2
Independent Claim 91 words
A method for the administration of a rectally absorbable, therapeutically effective ingredient which comprises inserting into the rectum through the anus a medicament capsule formed of a hard capsule shell made of an enterosoluble material selected from the group consisting of mixed esters of an alkylcellulose, a hydroxyalkylcellulose or a hydroxyalkyl alkylcellulose esterified with acidic succinyl groups and aliphatic monoacyl groups, and encapsulating a liquid content containing the rectally absorbable, therapeutically effective ingredient, the osmotic pressure of the liquid content being substantially higher than the osmotic pressure of the rectal fluid.
Claim 3
Dependent Claim 20 words
The process of claim 1 wherein the liquid content has a pH value in the range from 3.0 to 4.0.

References Cited (Backward Citations)

US3197369A Cited
US3467748A Cited
US3444290A Cited
US3656997A Cited
US4160020A Cited
US4265875A Cited
US4111202A Cited
US4111203A Cited
US4111201A Cited
US4226981A Cited
US4278633A Cited
US4339463A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-09-19 1987-03-21 1987-09-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-09-19 1991-03-21 1991-09-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-09-19 1995-03-21 1995-09-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag